VYNE Therapeutics Inc. (VYNE)

DFS Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	28.21	19.93	30.62	30.91	42.25	57.56
Short-Term Investments	22.06	41.59	62.63	-	-	1.03
Cash & Short-Term Investments	50.27	61.52	93.25	30.91	42.25	58.59
Cash Growth	-41.51%	-34.03%	201.71%	-26.85%	-27.89%	-18.75%
Accounts Receivable	-	-	-	-	7.58	15.82
Other Receivables	-	-	-	5	-	-
Receivables	-	-	-	5	7.58	15.82
Inventory	-	-	-	-	-	7.4
Prepaid Expenses	4.64	2.92	2.66	2.3	4.57	4.59
Restricted Cash	-	-	0.05	0.07	0.61	0.86
Other Current Assets	-	-	-	-	8.18	-
Total Current Assets	54.91	64.44	95.96	38.28	63.19	87.26
Property, Plant & Equipment	0.17	0.21	0.21	-	0.35	2.14
Other Long-Term Assets	1.34	2.26	1.52	2.48	3.51	4.35
Total Assets	56.42	66.91	97.69	40.76	67.05	93.74
Accounts Payable	3.53	2.71	1.66	2.39	6.51	4.78
Accrued Expenses	5.28	8.59	3.51	4.26	6.06	10.32
Current Portion of Leases	0.06	0.1	0.12	-	0.35	0.76
Current Unearned Revenue	-	-	-	-	-	5.8
Other Current Liabilities	3.41	3.42	2.25	2.7	5.49	0.1
Total Current Liabilities	12.29	14.82	7.54	9.35	18.41	21.77
Long-Term Debt	-	-	-	-	-	33.17
Long-Term Leases	-	-	0.1	-	-	0.85
Other Long-Term Liabilities	-	-	1.31	-	-	0.46
Total Liabilities	12.29	14.82	8.95	9.35	18.41	56.25
Common Stock	0	0	0	-	0.01	0
Additional Paid-In Capital	783.91	783.24	780.04	693.94	688.16	603.69
Retained Earnings	-739.78	-731.17	-691.34	-662.74	-639.53	-566.2
Comprehensive Income & Other	-	0.02	0.03	-	-	-
Total Common Equity	44.13	52.09	88.74	31.2	48.64	37.49
Shareholders' Equity	44.13	52.09	88.74	31.41	48.64	37.49
Total Liabilities & Equity	56.42	66.91	97.69	40.76	67.05	93.74
Total Debt	0.06	0.1	0.21	-	0.35	34.78
Net Cash (Debt)	50.21	61.42	93.04	30.91	41.9	23.81
Net Cash Growth	-41.46%	-33.99%	201.02%	-26.24%	76.01%	-36.75%
Net Cash Per Share	1.18	1.44	9.06	9.70	14.66	13.22
Filing Date Shares Outstanding	16.66	15.21	14.1	3.26	3.12	2.85
Total Common Shares Outstanding	15.96	14.83	14.1	3.23	2.98	2.4
Working Capital	42.62	49.62	88.43	28.93	44.78	65.49
Book Value Per Share	2.77	3.51	6.29	9.66	16.34	15.62
Tangible Book Value	44.13	52.09	88.74	31.2	48.64	37.49
Tangible Book Value Per Share	2.77	3.51	6.29	9.66	16.34	15.62
Machinery	0.12	0.12	-	-	0.85	0.94
Leasehold Improvements	-	-	-	-	0.06	0.06

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q